Cargando…
Infectious Retrovirus Is Inactivated by Serum but Not by Cerebrospinal Fluid or Fluid from Tumor Bed in Patients with Malignant Glioma
Intravenous gene transfer using recombinant retroviruses tends to suffer from a low infectious viral titer when conducted in vivo. This is, in part, caused by complement‐mediated proteolytic inactivation of the retrovirus in human serum. However, if the retroviruses were directly injected into the b...
Autores principales: | Shimizu, Keiji, Miyao, Yasuyoshi, Tamura, Masakazu, Kishima, Haruhiko, Ohkawa, Motohisa, Mabuchi, Eiichiro, Yamada, Masanobu, Hayakawa, Toru, Ikenaka, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920638/ https://www.ncbi.nlm.nih.gov/pubmed/8567389 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03013.x |
Ejemplares similares
-
Usefulness of a Mouse Myelin Basic Protein Promoter for Gene Therapy of Malignant Glioma: Myelin Basic Protein Promoter Is Strongly Active in Human Malignant Glioma Cells
por: Miyao, Yasuyoshi, et al.
Publicado: (1997) -
Retrovirus‐mediated Gene Transfer Targeted to Malignant Glioma Cells in Murine Brain
por: Yamada, Masanobu, et al.
Publicado: (1992) -
Massa versus Haller: Priority of the Cerebrospinal Fluid Discovery
por: HERBOWSKI, Leszek
Publicado: (2018) -
Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis
por: Rosadas, Carolina, et al.
Publicado: (2015) -
Evaluation of the Production and Absorption of Cerebrospinal Fluid
por: MIYAJIMA, Masakazu, et al.
Publicado: (2015)